Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00026689 · ClinicalTrials.gov registry record
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 903
- Enrollment target
NCT00026689: Completed study, sponsored by National Cancer Institute (NCI).
NCT00026689 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 903 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00026689 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 903 participants
- Enrollment target
Study Summary
Background: -This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols. Objectives: -To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols. Eligibility: -Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment. Design: -This is a screening protocol. No investigational treatments will be administered on this protocol.
Primary Outcome
Evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 903 participants |
| Start Date | 2000-09-11 |
| Est. Completion | 2019-02-25 |
What the finished NCT00026689 record still lists
NCT00026689 is an observational study that tracks outcomes without assigning an intervention. The registered 903 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00026689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00026689 about?
NCT00026689 is a clinical study titled "Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols". Background: -This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols. Objectives: -To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Ra...
What is the current status of trial NCT00026689?
This trial is currently completed. The enrollment target is 903 participants. The study started on 2000-09-11. Estimated completion is 2019-02-25.
Who is sponsoring clinical trial NCT00026689?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI